SCHEMBL5459067

SCHEMBL5459067

COc1cccc2nc(N)n(C)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.60
NQO2 P16083 6/20 0.47
FGFR1 P11362 1/20 0.46
DCPS Q96C86 1/20 0.46
MCHR1 Q99705 1/20 0.45
KDM4E B2RXH2 3/20 0.44
TLR8 Q9NR97 2/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
G6PD P11413 1/20 0.42
PKM P14618 1/20 0.42
CYP3A4 P08684 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30967464 0.80 PRMT5 (0.53) PRMT5MCHR1KDM4ETLR8POLB
SCHEMBL6653731 0.79 FGFR1 (0.50) NQO2FGFR1DCPSKDM4ENPC1
SCHEMBL5457312 0.77 PRMT5 (0.66) PRMT5KDM4ETLR8NPC1RAB9A
SCHEMBL3860530 0.76 TLR8 (0.61) PRMT5NQO2MCHR1KDM4ETLR8
SCHEMBL14685292 0.76 RAB9A (0.54) NQO2FGFR1NPC1RAB9AMAPT
SCHEMBL1161336 0.76 RAB9A (0.47) NQO2FGFR1KDM4ENPC1RAB9A
SCHEMBL5448072 0.75 PRMT5 (0.64) PRMT5KDM4ETLR8POLBHTT
SCHEMBL5104145 0.75 PRMT5 (1.00) PRMT5KDM4ETLR8POLBHTT
SCHEMBL5461771 0.73 PRMT5 (0.53) PRMT5KDM4ETLR8LMNAPKM
SCHEMBL6530152 0.72 CYP2D6 (0.50) KDM4EMAPTLMNAPOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed
WO-2007084728-A2 2-IMINO-BENZIMIDAZOLES ABBOTT LABORATORIES (US) 2007-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 PRMT5 2145/4885NQO2 329/4885FGFR1 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.